Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAnpario Regulatory News (ANP)

Share Price Information for Anpario (ANP)

Share Price is delayed by 15 minutes
Get Live Data
520.00    5.00 (0.97%)
Bid:
510.00
Ask:
530.00
Spread: 20.00 (3.922%)
Market Cap: £85.47m
ANP Live PriceLast checked at - London Stock Exchange

Intraday Anpario Share Chart

AGM Statement

25 Jun 2024 07:00

RNS Number : 6762T
Anpario PLC
25 June 2024
 
Anpario plc("Anpario", "Group" or the "Company")

 

AGM Statement

 

 

Anpario plc, the independent manufacturer of natural sustainable animal feed additives for health, nutrition and biosecurity, is holding its AGM later today, at which Matthew Robinson, Chairman, will make the following statement:

 

"The Group has delivered a strong sales performance and a corresponding improvement in profit in the first half of the year as the global agriculture market continues to improve and we are confident of achieving market expectations for the full year. There are still challenges to navigate and as highlighted at the time of our 2023 full year results announcement on 20 March 2024, we expected individual territory performance to be variable. In contrast to the strong first half performances last year in the United States and Australia, both territories have experienced weaker trading in the current period. However, all other regions have delivered strong sales growth with notable performances from Asia Pacific, Middle East and Africa and South America, demonstrating the resilience afforded by our geographic diversity.

 

The Group's business development initiatives are centred around expanding in the ruminant and aquaculture sectors as well as working with several partners in pet food where we can offer natural sustainable solutions. Our unique water-soluble phytogenic product Orego-Stim® Forte, for aquatic species, continues to show excellent field trial results, especially for inhibiting the growth of Vibrio species of bacteria in the absence of antibiotics. As such we are experiencing strong interest for this product from across the aquaculture industry.

 

Raw material prices have stabilised and together with increased volumes through our highly automated production facility we are delivering improved gross margins and profitability. Our cash position has improved further since the year end, with a balance of £12.2m as at 31 May 2024, giving us a strong financial position with which to continue to grow the business, both organically and through acquisitions, should the right opportunities arise."

 

The Company's interim results for the six months period ended 30 June 2024 are expected to be announced on 11 September 2024. 

 

 

 

Enquiries

 

Anpario plc

Richard Edwards, Chief Executive Officer

+44(0)7776 417 129

Marc Wilson, Group Finance Director

+44(0)1909 537 380

Shore Capital

 

(Nominated Adviser and Broker)

+44 (0) 20 7408 4090

Stephane Auton

Corporate Advisory

David Coaten

Tom Knibbs

Henry Willcocks

Corporate Broking

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGMFLFLTREISFIS
Date   Source Headline
30th Jan 20207:00 amBUSTrading Statement
20th Jan 202010:05 amRNSHolding(s) in Company
17th Jan 20204:55 pmRNSBlock listing Interim Review
17th Jan 20209:40 amRNSHolding(s) in Company
13th Jan 202010:31 amRNSHolding(s) in Company
8th Jan 20203:39 pmRNSHolding(s) in Company
6th Jan 202011:04 amRNSHolding(s) in Company
18th Nov 20195:30 pmRNSHolding(s) in Company
5th Nov 20199:44 amRNSHolding(s) in Company
11th Sep 20197:00 amBUSHalf-year Report
14th Aug 201911:10 amRNSHolding(s) in Company
13th Aug 20196:08 pmRNSHolding(s) in Company
17th Jul 201910:41 amRNSBlock listing Interim Review
27th Jun 20194:23 pmRNSResult of AGM
27th Jun 20197:00 amRNSAGM Statement
21st Jun 20197:00 amRNSTotal Voting Rights
5th Jun 201910:47 amRNSDirector/PDMR Shareholding
4th Jun 20195:35 pmRNSPosting of Annual Report and Notice of AGM
24th Apr 20193:27 pmRNSHolding(s) in Company
17th Apr 20192:04 pmRNSHolding(s) in Company
2nd Apr 201910:33 amRNSTotal Voting Rights
8th Mar 201911:06 amRNSFinal Results
6th Mar 20197:00 amBUSFinal Results
5th Mar 20194:17 pmRNSTotal Voting Rights
29th Jan 20197:00 amRNSPre-Close Trading Statement
17th Jan 201912:17 pmRNSBlock listing Interim Review
6th Dec 20182:30 pmRNSHolding(s) in Company
6th Dec 20182:25 pmRNSHolding(s) in Company
2nd Oct 20183:51 pmRNSTotal Voting Rights
5th Sep 20187:00 amRNSHalf-year Report
31st Jul 20189:54 amRNSHolding(s) in Company
19th Jul 20183:30 pmRNSBlock listing Interim Review
28th Jun 20184:05 pmBUSResult of AGM
28th Jun 20187:00 amRNSAGM Statement
5th Jun 20183:58 pmRNSAnnual Report and Notice of AGM
4th Jun 20183:17 pmRNSTotal Voting Rights
4th May 201812:05 pmRNSTotal Voting Rights
9th Apr 20188:25 amRNSTotal Voting Rights
7th Mar 20187:00 amBUSFinal Results
5th Mar 20183:16 pmRNSHolding(s) in Company
5th Feb 20182:21 pmRNSTotal Voting Rights
29th Jan 20187:00 amRNSTrading Statement
19th Jan 20182:32 pmRNSBlock listing Six Monthly Return
22nd Nov 20174:53 pmRNSEmployee Share Plan and Directors' Dealing
20th Oct 20177:00 amRNSDirectorate Change
21st Sep 20173:30 pmRNSDirector/PDMR Shareholding
21st Sep 20173:30 pmRNSDirector/PDMR Shareholding
19th Sep 20177:00 amBUSHalf-year Report
28th Jul 20179:46 amRNSBlock Listing Return
18th Jul 20174:58 pmRNSDirector/PDMR Shareholding and Issue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.